Macrovascular and microvascular dysfunction in the metabolic syndrome

Area of Science:

• Cardiovascular Physiology
• Metabolic Disorders

Background:

• Metabolic syndrome (MetS) is a cluster of conditions increasing the risk of type-2 diabetes and cardiovascular disease (CVD).
• Arterial dysfunction, affecting both large and small vessels, may precede overt diabetes or CVD in MetS patients.

Purpose of the Study:

• To investigate macrocirculatory (large artery) and microcirculatory (small artery) function in individuals with MetS.
• To determine if MetS is associated with impaired pulse-wave velocity (PWV) and skin capillary density (CD) in the absence of diagnosed diabetes or CVD.

Main Methods:

• A comparative study involving 36 MetS subjects and 108 controls from the SU.VIM.AX-2 cohort.
• Assessment of pulse-wave velocity (PWV) for large artery stiffness and skin capillary density (CD) for microcirculatory function.
• Statistical analysis including multivariate models to identify associations between MetS components and circulatory parameters.

Main Results:

• MetS subjects showed significantly higher PWV (indicating stiffer large arteries) and lower functional CD (indicating impaired microcirculation) compared to controls.
• Functional CD was inversely correlated with fasting glucose, triglycerides (TGs), and HOMA-IR, suggesting a link to metabolic dysregulation.
• Impaired PWV was associated with systolic blood pressure and TGs, while impaired CD was associated with TGs and fasting glucose.

Conclusions:

• Metabolic syndrome is associated with both macrocirculatory and microcirculatory dysfunction, even before the onset of diabetes or clinical CVD.
• Metabolic factors, particularly insulin resistance, appear to be key mediators linking MetS components to arterial dysfunction and subsequent CVD risk, rather than elevated blood pressure alone.